Health Trials

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

ConditionChronic Heart Failure
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19-64
SponsorAddpharma Inc.

About this trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects

Eligibility criteria

Qualifiers

Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit

Subjects aged 19 years or older and under 65 years at the screening visit

Disqualifiers

Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration

Other exclusions applied

Trial design

Treatments tested in this trial

  • AD-118, AD-1181

Treatment groups

70 Participants
are divided into 2 treatment groups

Locations

1
H PLUS YANGJI HOSPITAL, Seoul Seoul South Korea

Sponsors and collaborators

Addpharma Inc.

Lead sponsor

Source ClinicalTrials.gov